Medicare Part D RBC Subgroup letter to the Centers for Medicare and Medicaid Services for financial data related to Medicare Part D, which will be used to update a report on Medicare Part D RBC risk factors. (
)
Health RBC Trend Test Work Group report to the NAIC on evaluating the effectiveness of three proposed trend tests. (
)
Health Practice Financial Reporting Committee comments on proposed changes in the actuarial opinion instructions for NAIC health annual statements. (
)
Joint Committee on Retiree Health letter to Texas officials about misinterpretations of the committee's 2006 comments on accounting standards for OPEBs. (
)
Medicare Part D RBC Subgroup revision proposals to the NAIC life and health RBC instructions for Medicare Part D to address a potential unintended consequence related to the Authorized Control Level (ACL) RBC results. (
)
Health Practice Financial Reporting Committee letter to Julia T. Philips, the Chair of the NAIC's Health Risk-Based Capital (RBC) Working Group, that comments on a proposal made by Blue Cross Blue Shield of Florida regarding the treatment in the NAIC RBC formulas of medical insurance products for which active life reserves are held. The letter provided initial thoughts on the matter and seeks further input from the NAIC in light of these thoughts. (
)
Health Practice Financial Reporting Committee comments to the NAIC on a proposal to include a trend test in the health RBC formula. (
)
Medicare Part D RBC Subgroup comment letter to NAIC's Health Risk Based Capital Working Group on a possible update of proposed risk factors previously developed by the Academy's Medicare Part D subgroup. (
)
Part D Lessons Learned Work Group comment letter on what has worked well and what has not in Medicare Part D. The letter also offers recommendations to improve the overall operation and administration of the Part D program, specifically including the bidding process, management of eligibility, and coordination with Medicaid and with the Social Security Administration. (
)
Health Practice Council comment letter to members of the House and Senate on the actuarial implications of restricting insurers' use of genetic information. (
)
